Section 174 of the Internal Revenue Code governs the treatment of Specified Research or Experimental (SRE) expenditures. The Tax Cuts and Jobs Act (TCJA) of 2017 amended Section 174, requiring businesses to amortize SRE expenditures over time rather than deducting them in full in the year they are incurred. While this blog focuses on manufacturing, businesses in other industries, such as pharma and technology, can also benefit.
Understanding Section 174 Amortization
Before 2022, businesses could deduct qualified research expenses in the year they were incurred. However, for tax years beginning after December 31, 2021, Section 174 mandates that domestic R&E expenditures be amortized over five years, while foreign R&E expenditures must be amortized over fifteen years. This change significantly impacts cash flow and tax liabilities, particularly for manufacturers relying on R&D to stay competitive. The inability to immediately deduct R&E costs means businesses face higher taxable income in the short term, potentially increasing their tax burden and requiring more strategic financial planning.
What is Amortization, and How is it Different from Depreciation?
Amortization and depreciation are accounting methods used to allocate the cost of assets over time, but they apply to different expenses.
Amortization refers to the gradual expense recognition of intangible assets, such as research and experimental expenditures, patents, or trademarks. It spreads these costs over a fixed period, aligning expenses with the period in which they provide value.
Depreciation, on the other hand, applies to tangible assets like machinery, equipment, and buildings. It accounts for the wear and tear of physical assets over their useful life.
The key difference is that amortization deals with intangible assets and usually follows a straight-line method. In contrast, depreciation allows different methods, such as straight-line or accelerated depreciation, for tangible assets.
Key Differences Between Section 174 and the R&D Tax Credit (Section 41)
Many business owners and financial teams confuse Section 174 with Section 41, which governs the Research and Development (R&D) Tax Credit. While related, they serve distinct purposes. Section 174 applies to a broad range of R&E expenditures, including payroll, supplies, patent costs, rent, utilities, and overhead costs, all of which must be amortized over time. In contrast, Section 41 provides a tax credit for specific qualified research expenses (QREs), such as taxable wages, research-related supplies, 65% of qualified contractor costs, and certain cloud computing expenses. Importantly, amortization under Section 174 is mandatory, even if a company does not claim the R&D Tax Credit. Since most expenses that qualify for Section 41 also fall under Section 174, manufacturers should work closely with tax professionals to maximize available credits while maintaining compliance with amortization requirements.
How Section 174 Impacts Manufacturers
Manufacturers invest significantly in innovation to refine processes, create new products, and boost efficiency. These expenses are often substantial, making the shift from immediate deduction to amortization a financial challenge. The inability to fully deduct R&E costs upfront means higher taxable income in the first few years of amortization, requiring companies to adjust financial planning to account for these changes. Additionally, amortizing R&E expenditure could reduce the immediate cash savings manufacturers previously relied on from tax deductions. Strategic tax planning is necessary to ensure that this shift does not hinder investment in innovation.
The IRS mandates that manufacturers maintain detailed documentation to substantiate R&E expenditures, ensuring compliance with tax regulations. To navigate these challenges, manufacturers should implement thorough record-keeping practices and work with tax professionals to ensure that all qualifying expenditures are properly accounted for.
Strategies for Mitigating Section 174 Challenges
Manufacturing companies can adopt various strategies to offset the financial impact of Section 174. One approach is to maximize R&D tax credits, as Section 41 provides a dollar-for-dollar reduction in tax liability. Leveraging this credit can help mitigate the financial strain caused by amortization. Additionally, businesses should reevaluate expense classification, ensuring that only qualifying expenditures are categorized under Section 174.
Another strategy is adjusting financial forecasting. Because the timing of tax deductions has changed, manufacturers should update cash flow models to account for the impact of amortization. Companies should also explore additional tax incentives, such as state-level R&D and bonus depreciation, to reduce overall tax liabilities. By employing these strategies, manufacturers can navigate Section 174’s challenges while maintaining their focus on innovation and growth.
Potential Future Changes to Section 174
While there has been bipartisan support to reverse or modify the amortization requirement, businesses must comply with the current law. The likelihood of a retroactive fix remains low, making it essential for manufacturers to plan accordingly. Companies should monitor legislative updates and be prepared to adjust their strategies if changes occur.
Final Thoughts
The transition from immediate deduction to amortization under Section 174 presents challenges for businesses across various industries, including manufacturing, pharmaceuticals, and technology. While each sector engages in distinct research or experimental activities, all can benefit from proactive tax planning and strategic financial management. By working closely with the tax professionals at Stephano Slack, businesses can ensure compliance, optimize tax positions, and continue investing in the innovation necessary to remain competitive in today’s evolving market.
Understanding and proactively addressing Section 174 requirements will help businesses across multiple sectors avoid penalties, maximize available credits, and maintain financial stability while continuing to innovate and grow. Contact your Stephano Slack tax manager/partner at 610-687-1600 or taxinfo@StephanoSlack.com to discuss your situation.
Author Robert Radzinski, CPA, Manager, manages tax compliance for businesses and high net worth individuals. Rob can be contacted at 610-687-1600 or rradzinski@stephanoslack.com.
Recent Comments